Aquestive Therapeutics, Inc. Loss Contingency, Number of Defendants
Aquestive Therapeutics, Inc. (AQST) reported Loss Contingency, Number of Defendants of 6 Company for the 1-month period ending 2013-08-31, per its 10-Q filed 2020-11-04.
Discontinued › Notes › Commitment and Contingencies › Loss Contingency › Loss Contingency, Information about Litigation Matters
us-gaap:LossContingencyNumberOfDefendants · last filed 2020-11-04
- 2013-08-31: Loss Contingency, Number of Defendants 1 month 6.00 Company.
| Period end | Loss Contingency, Number of Defendants 1 month |
|---|---|
| 2013-08-31 | 6.00 Company 10-Q · filed 2020-11-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |